Neurons expressing neuropeptide Y receptor 1 (NPY1R) represent a critical component of the neuropeptide Y signaling system in the central nervous system. NPY1R is a G protein-coupled receptor (GPCR) that binds neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) with high affinity. These receptors are widely distributed throughout the brain and play essential roles in regulating feeding behavior, energy homeostasis, anxiety, stress responses, and neuroprotection.
NPY1R-expressing neurons are found in several key brain regions:
- Hypothalamus: Particularly in the arcuate nucleus (ARC), paraventricular nucleus (PVN), and lateral hypothalamus, where they regulate feeding and energy balance
- Amygdala: Central nucleus and basolateral amygdala, involved in emotional processing and anxiety
- Cortex: Prefrontal cortex and piriform cortex, participating in cognitive functions
- Hippocampus: Dentate gyrus and CA regions, implicated in memory and neuroprotection
- Thalamus: Paraventricular nucleus, involved in stress responses
- Brainstem: Nucleus tractus solitarius (NTS), regulating autonomic functions
NPY1R is a 36-kDa GPCR belonging to the NPY receptor family (Y1 subtype). The receptor:
- Couples primarily to Gi/o proteins, inhibiting adenylate cyclase and reducing cAMP production
- Activates MAPK signaling pathways including ERK1/2
- Modulates calcium channels and potassium conductances
- Exhibits constitutive activity in some neuronal populations
- Undergoes homologous desensitization via GRK phosphorylation and β-arrestin recruitment
NPY1R neurons mediate diverse neurophysiological functions:
- Integrate metabolic signals (leptin, insulin, ghrelin)
- Promote satiety signaling in the hypothalamus
- Regulate food intake and energy expenditure
- Modulate white adipose tissue metabolism via sympathetic outflow
¶ Anxiety and Stress Responses
- Mediate anxiogenic effects of NPY in the amygdala
- Modulate HPA axis activity and corticosterone release
- Interact with CRH and corticosterone systems
- Influence fear conditioning and extinction
- Modulate synaptic plasticity in hippocampus
- Influence learning and memory processes
- Regulate hippocampal excitability
- Protect against excitotoxicity
- Activate anti-apoptotic signaling (PI3K/Akt pathway)
- Reduce calcium influx during excitotoxic stress
- Modulate inflammatory responses in microglia
- Promote neuronal survival in models of neurodegeneration
- NPY levels are altered in AD brains, with reduced NPY expression in certain regions
- NPY1R signaling may protect against amyloid-beta toxicity
- Polymorphisms in NPY1R gene associated with AD risk in some populations
- Therapeutic potential: NPY1R agonists may offer neuroprotective effects
- NPY1R neurons in the basal ganglia modulate dopaminergic signaling
- Altered NPY expression observed in PD brains
- Potential role in regulating motor function and levodopa-induced dyskinesias
¶ Depression and Anxiety Disorders
- Dysregulated NPY1R signaling associated with stress vulnerability
- NPY1R antagonists show anxiolytic effects in preclinical models
- Target for novel antidepressant development
- NPY1R antagonists being explored as anti-obesity agents
- Role in leptin resistance and metabolic syndrome
- Interactions with melanocortin system
- NPY1R signaling has anti-convulsant properties
- Decreased NPY1R expression in epileptic tissue
- Gene therapy approaches using NPY delivery under investigation
NPY1R represents a promising therapeutic target:
- Synthetic NPY analogs: Designed for neuroprotection
- Small molecule agonists: Under development for cognitive enhancement
- Peptide-NPY conjugates: Targeting specific brain regions
- BIIE-0246: Selective NPY1R antagonist, research tool
- JNJ-52077874: Brain-penetrant NPY1R antagonist
- Clinical candidates: For obesity and anxiety disorders
- Neurodegenerative diseases: NPY1R agonists for AD/PD
- Metabolic disorders: NPY1R antagonists for obesity
- Anxiety/depression: NPY1R modulators
- Epilepsy: NPY-based gene therapy
NPY1R expression serves as a biomarker:
- Genetic markers: NPY1R polymorphisms associated with disease risk
- Expression levels: NPY1R mRNA in peripheral blood mononuclear cells
- Functional imaging: PET ligands for NPY1R under development
- Cerebrospinal fluid: NPY and NPY1R levels as neurodegeneration markers
- Neuropeptide Y receptors: from molecular pharmacology to clinical therapeutics (2016)
- NPY and Alzheimer's disease: A critical relationship (2020)
- Neuropeptide Y signaling in the basal forebrain (2019)
- NPY1R gene polymorphisms and obesity (2021)
- NPY1R agonists for neuroprotection (2018)
- Targeting NPY receptors for anxiety disorders (2022)